Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Benedictuson Mar 23, 2024 7:17am
257 Views
Post# 35948568

RE:RE:The numbers don't tell the whole story...

RE:RE:The numbers don't tell the whole story...

Alamir1111 wrote: Guess you're right 39million $market cap 287 millions of shares out 

Current capital structure is on pg 22 of latest corp presentation. Fully diluted just shy of 345M. But certainly on track to see all those .35c wts expire as they incrementally get replaced by quarterly private placement warrants at far lower strikes.

Recruitment rate is extremely concerning and Roger needs to address it in his next update. Why  have no patients been enrolled for almost 6 months and why are CSS's dropping instead of increasing? We were purportedly to be out of the pre BTD phase by end of Q1, just a week away. Now that we have all the signs of the coffers running dry again (i.e. stock price collapsing on volume, newly updated investor deck, yet another email from the CoB) Roger will be forced to give a fullsome update if he wants that money.  I say fullsome but in reality I'm sure he will leave us all still trying to read between the lines. 

<< Previous
Bullboard Posts
Next >>